Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Bone Reports|January 26, 2023
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional studyRebecca Pedersini, Deborah Cosentini, Luca Rinaudo, et al.
In Vivo (Athens, Greece)|June 23, 2022
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer PatientsRebecca Pedersini, Pierluigi DI Mauro, Manuel Zamparini, et al.
JBMR Plus|February 22, 2021
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor TherapySara Monteverdi, Rebecca Pedersini, Fabio Gallo, et al.
BMC Cancer|March 18, 2014
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT studyAlfredo Berruti, Nicola Fazio, Anna Ferrero, et al.
Scientific Reports|June 22, 2021
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapyRebecca Pedersini, Pierluigi di Mauro, Sara Bosio, et al.
JAMA Network Open|September 28, 2019
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor TherapyRebecca Pedersini, Vito Amoroso, Filippo Maffezzoni, et al.
Neuroendocrinology|August 31, 2022
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT StudyPiero Ferolla, Alfredo Berruti, Francesca Spada, et al.
International Journal of Nursing Practice|September 22, 2020
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the deviceRebecca Pedersini, Carla Fornaro, Pierluigi di Mauro, et al.
Journal of Geriatric Oncology|April 18, 2020
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world dataRebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, et al.
Breast Cancer Research and Treatment|January 20, 2026
Fracture risk in metastatic breast cancer patients treated with CDK 4/6 inhibitors and endocrine therapyRebecca Pedersini, Laura Moretti, Marta Laganà, et al.
Pageof 6